Kit ELISA LYVE1 sandwich (human): quantitative determination of Hu LYVE1 in serum, plasma or cell culture medium. The test recognizes only the natural and recombinant forms of Hu LYVE1.
Kit ELISA LYVE1 sandwich (human): quantitative determination of Hu LYVE1 in serum, plasma or cell culture medium. The test recognizes only the natural and recombinant forms of Hu LYVE1.
Method principle: This ELISA solid phase sandwich test (immuno-enzymatic dose) measures the amount of target bound between a pair of matched antibodies. A specific target antibody is pre-adsorbed into the wells of the supplied microplate. Samples, standards or controls are added to these wells and bind to immobilized antibodies (capture antibodies). The sandwich is formed by adding the second antibody (detection antibody), then a substrate solution reacts with the enzyme-antibodies-target complex to produce a measurable signal. The intensity of this signal is directly proportional to the concentration of the target present in the original sample.
Rigorous validation: Each batch manufactured from this ELISA kit is checked for criteria such as sensitivity, specificity, accuracy and reproducibility from one batch to another (see the package leaflet for more information on validation).
LYVE1 was identified as a major receptor for HA (hyaluronane, extracellular matrix glycosaminoglycan) on the lymphatic vessel wall. The amino acid sequence derived from LYVE1 predicted a 322-type full membrane polypeptide type I residues similar to the CD44 HA receptor with a 212-residue extracellular domain containing a single Link module, the prototypic HA binding domain of the Link protein superfamily. Like CD44, the LYVE1 molecule binds soluble HAs and immobilized HAs. However, unlike CD44, the LYVE1 molecule colocates with HA on the luminal side of the lymphatic vessel wall and is completely absent from the blood vessels. Therefore, LYVE1 is the first lymph specific HA receptor to be characterized and is a unique and powerful marker for the lymphatic vessels themselves. LYVE1 is a Type I integral membrane glycoprotein. LYVE-1 is primarily expressed on the endothelium of the lymphatic vessels and is likely to be involved in regulating the trafficking of leukocytes and tumour cells to the lymph nodes. Lymphatic vasculature forms a second circulatory system that drains extracellular fluid from tissues and provides an exclusive environment in which immune cells can meet and respond to foreign antigens. Several molecules were identified as markers for lymphatic lheendothelium that include LYVE1, PALE, VEGFR3 and podoplanin. Among the diseases associated with LYVE1 dysfunction, there is complete androgen insensitivity syndrome.
Sensitivity
Sensitivity of dosage: 8 pg/ml.
Measurement range
Dosing range: 8.19 pg/ml to 2.000 pg/ml.
Duration of dosing
Total dosage duration: 4 hours 45 min.
Samples
Sample type: Plasma, Serum, Surnatant (plasma volume, 1 μl; serum, 1 μl; supernatant, 100 μl).
Technical specifications
| General |
| Brand | Invitrogen |
| Supplier ref. (Fisher Scientific) | 17185499 |
| Specifications |
| Accession number | Q9Y5Y7 |
| Dose range | 8.19 pg/ml to 2.000 pg/ml |
| Sensitivity of the dosage | 8 pg/ml |
| Calibration range | 8 pg/ml to 2000 pg/ml |
| Dose | ELISA solid-phase sandwich |
| Conjugate | Biotin |
| Product type | Kit ELISA |
| Protein family | Cell structure & organic proteins |
| Type of sample | Plasma, Serum, Surnatant |
| Specificity | This ELISA kit shows no cross-reactivity with the following tested cytokines: human angiogenin, BDNF, BLC, ENA-78, FGF- 4, IL-1 alpha, IL-1 beta, IL-2, IL-3, IL-4, IL-5, IL-6, IL-7, IL-8, IL-9, IL-11, IL-12 p70, IL-12 p40, IL-13, IL-15, IL-309, IP-10, G-CSF, GM-CSF, IFN-gamma, leptin ( |
| Sufficient for | 5 x 96 dosages |
| Target species | Human |
| For use with (application) | ELISA, protein dosage, protein biology, cancerology, immunology, neuroscience, neurobiology, protein detection, protein analyses |
| For use with (equipment) | Colorimetric microplate reader |
| Genetic identification (Enter) | 10894 |
| Gene symbol(s) | CRSBP-1,HAR,LYVE-1,XLKD1 |
| Coefficient of inter-dose variation | <12% |
| Coefficient of intra-dose variation | <10% |
| Contents of kits | 96-well pre-coated plates, Chromogen, Wash pad, Stop solution, Adhesive plate covers, Dosing diluent concentrate, SAV-HRP, Biotinylated detection antibody, Calibration |
| Marker or dye | HRP |
| Quantity | 5 x 96 tests |
| Regulatory status | RUO |
| Research disciplines | Cellular cycle & proliferation |
| Synonym | UNQ230/PRO263, CRSBP-1, HAR, LYVE-1, XLKD1 |
| Target | Human |
| Test time | 1 hour 20 minutes. |
| Physical characteristics |
| Volume of sample | Plasma, 1 μl; serum, 1 μl; supernatant, 100 μl |
| Storage and shipping |
| Storage conditions | 2°C to 8°C |
| Total duration of dosing | 4:45 a.m. |
Origin and customs
| Manufacturer ref. | EHLYVE1X5 |
|---|
| Country of origin | United States |
|---|
A question or a specific configuration?
Contact us for a quote.